MedTrace Logo

Trends in Risk Factors for Mother-to-Child Transmission of Hepatitis C Among a Southern European Population

NCT00894257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2023-11-13

No results posted yet for this study

Summary

According to the centres taking part in the ALHICE survey, the number of HIV-HCV co-infected women is currently decreasing. This drop was first noted in 2006 and persisted in 2007. What might have been considered a chance phenomenon during the first year (2006) was confirmed in the beginning of 2008. In view of this information, the investigators wished to ascertain the reality of this trend and to investigate its causes, by attempting to answer the following questions: - Has the prevalence of risk factors for HCV infection changed among the general population over the past 10 years?

* Has the prevalence of risk factors for HCV infection changed among HIV/HCV co-infected women over the past 10 years?
* Is the change in the number of co-infected women who gave birth during the past 10 years related to the prevalence of certain risk factors among this population?
* Is the change in the number of co-infected women who gave birth during the past 10 years related to a decrease in certain risk factors for HCV infection among the general population?
* Have changes in addictive behaviour among women of child-bearing age played a role in the decreasing number of HCV-contaminated children? Furthermore, follow-up data from HCV-infected children born during this period will provide information concerning the course of HCV infection.

The objectives are to study trends in numbers of deliveries among HCV/HIV co-infected women as well as trends in risk factors for HCV infection among women of child bearing age and lastly to create a cohort of HCV infected children.

Conditions

  • Hepatitis C Virus
  • HIV Infections
  • Pregnancy

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Principal Investigators

  • Eugénia MARINE-BARJOAN, MD · Centre Hospitalier Universitaire de Nice

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-25
Primary Completion
2014-04-15
Completion
2014-04-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00894257 on ClinicalTrials.gov